Menadione topical lotion for the prevention of skin toxicity associated with epidermal growth factor receptor inhibitor class anticancer therapy results in negligible systemic exposure to menadione - 16/03/14
Lisa Zhang, Northwestern University Feinberg School of Medicine, Department of Dermatology, Chicago, IL, United States; Mario Lacouture, MD, Memorial Sloan-Kettering Cancer Center, New York, NY, United States; Milan Anadkat, MD, Washington University School of Medicine, Division of Dermatology, St. Louis, MO, United States; Pranathi Lingam, MD, Northwestern University Feinberg School of Medicine, Department of Dermatology, Chicago, IL, United States; Steven Deitcher, MD, Talon Therapeutics, South San Francisco, CA, United States; Vera Hirsh, MD, McGill University Department of Dermatology, Montreal, Quebec, Canada
Le texte complet de cet article est disponible en PDF. Commercial support: None identified. |
Vol 70 - N° 5S1
P. AB152 - mai 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?